Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications. Current t…
Endocannabinoid System and Psychotic Disorders: Clinical
Clinical Takeaway Cannabis-induced psychosis frequently precedes diagnosis of schizophrenia spectrum or bipolar disorder, with patients requiring careful long-term psychiatric monitoring rather than reassurance about symptom resolution. The overlap between cannabis-triggered and primary...
Endocannabinoid System and Psychosis Risk: Clinical Evidence
Clinical Takeaway Cannabis-induced psychosis increases the risk of subsequently developing schizophrenia spectrum and bipolar disorder, with prevalence rates varying significantly across studies. Patients experiencing cannabis-induced psychosis require careful diagnostic evaluation and monitoring...
Endocannabinoid System Clinical Research on Psychosis Risk
Clinical Takeaway Patients who experience cannabis-induced psychosis have a documented risk of subsequently developing schizophrenia spectrum or bipolar disorder, with prevalence varying across studies due to differences in follow-up duration and diagnostic...
`Cannabis-Induced Psychosis: Schizophrenia & Bipolar Risk`
Clinical Takeaway A significant proportion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign...
`Cannabis Psychosis to Schizophrenia: Clinical Evidence Review`
Clinical Takeaway A significant portion of people diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign...
`Cannabis-Induced Psychosis & Schizophrenia Risk: Key Research`
Clinical Takeaway A significant portion of patients diagnosed with cannabis-induced psychosis go on to develop a primary psychiatric disorder such as schizophrenia spectrum disorder or bipolar disorder over time. Clinicians should treat...
`Cannabis-Induced Psychosis and Psychotic Disorders: Key Evidence`
Clinical Takeaway A significant proportion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign...
Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis.
Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications. Current t…
`Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk`
Clinical Takeaway A significant portion of patients diagnosed with cannabis-induced psychosis go on to develop a primary psychiatric disorder such as schizophrenia spectrum disorder or bipolar disorder. Clinicians should treat cannabis-induced psychosis...